The mechanisms that may be inhibited by ADO include the activation, differentiation, and clonal expansion of tumor‐specific T cells with helper and cytotoxic effector functions, as well as cytotoxic T cells (CTL) binding to syngeneic tumor cells, and tumor cell destruction by NK cells, lymphokine‐activated killer cells, and CTL. This evidence concerns the gene ADO and neoplasm.